Correction of X-Linked Hyper-IgM Syndrome by Allogeneic Bone Marrow Transplantation

  • Thomas C
  • de Saint Basile G
  • Le Deist F
  • et al.
86Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The X-linked hyper-IgM syndrome is a rare immunodeficiency disease in which the ability of B cells to switch immunoglobulin production from IgM to IgG, IgA, and IgE is defective.1A variety of mutations of the gene encoding the CD40 ligand cause the immunodeficiency.2-6The functional effect of the mutation is that the CD40 ligand on T cells cannot interact with the CD40 glycoprotein on the surface of B cells. This interaction normally mediates immunoglobulin class switching by B cells. The deficiency of IgG and IgA leads to recurrent infections of the respiratory tract that can be prevented by intravenous. . . © 1995, Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Thomas, C., de Saint Basile, G., Le Deist, F., Theophile, D., Benkerrou, M., Haddad, E., … Fischer, A. (1995). Correction of X-Linked Hyper-IgM Syndrome by Allogeneic Bone Marrow Transplantation. New England Journal of Medicine, 333(7), 426–429. https://doi.org/10.1056/nejm199508173330705

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free